Arcturus Therapeutics Ltd (NASDAQ:ARCT)

9.40
Delayed Data
As of Jun 22
 +0.42 / +4.68%
Today’s Change
4.78
Today|||52-Week Range
15.19
+18.24%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Arcturus Therapeutics Ltd have a median target of 21.00, with a high estimate of 22.00 and a low estimate of 20.00. The median estimate represents a +123.40% increase from the last price of 9.40.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Arcturus Therapeutics Ltd. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.50
Sales
$0.00
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 24.24%
 
 
 
 
 
 
Growthannually -153.09%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.